Gleason Shane Thomas, Chief Commercial Officer of InspireMD, Inc. ($NSPR), sold shares on the open market 10 times over the last 365 days, totaling $99,330.56. His most recent sale occurred on February 2, 2026. These $NSPR insider sales rank 9,603rd among 11,678 individuals in our database, where the average sale amount is $8.6 million across about 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2000 | $1.60 | 1,139,177.0000 | 73,466,501 | 0.18% | 0.00% |
| Jan. 15, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2909 | $1.58 | 1,197,462.0000 | 73,466,501 | 0.24% | 0.00% |
| Jan. 16, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2250 | $1.61 | 1,195,212.0000 | 73,466,501 | 0.19% | 0.00% |
| Jan. 20, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2955 | $1.59 | 1,192,257.0000 | 73,466,501 | 0.25% | 0.00% |
| Jan. 21, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 17593 | $1.62 | 1,174,664.0000 | 73,466,501 | 1.48% | 0.02% |
| Jan. 22, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 8411 | $1.57 | 1,166,253.0000 | 73,466,501 | 0.72% | 0.01% |
| Jan. 27, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 4781 | $1.66 | 1,161,472.0000 | 73,466,501 | 0.41% | 0.01% |
| Jan. 28, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 12395 | $1.65 | 1,149,077.0000 | 73,466,501 | 1.07% | 0.02% |
| Jan. 29, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 5000 | $1.65 | 1,144,077.0000 | 73,466,501 | 0.44% | 0.01% |
| Jan. 30, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2900 | $1.63 | 1,141,177.0000 | 73,466,501 | 0.25% | 0.00% |
| Jan. 14, 2026 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 453390 | $0.00 | 1,200,371.0000 | 73,466,501 | 60.70% | 0.62% |
| Jan. 7, 2025 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 106218 | $0.00 | 289,346.0000 | 41,928,360 | 58.00% | 0.25% |
| Jan. 7, 2025 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 232616 | $0.00 | 746,981.0000 | 41,928,360 | 45.22% | 0.55% |
| Jan. 23, 2024 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 238625 | $0.00 | 514,365.0000 | 24,268,181 | 86.54% | 0.98% |
| Jan. 23, 2024 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 91218 | $0.00 | 183,128.0000 | 24,268,181 | 99.25% | 0.38% |
| Aug. 28, 2023 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 19290 | $0.00 | 275,740.0000 | 0 | 7.52% | 0.00% |
| Aug. 28, 2023 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 6430 | $0.00 | 91,910.0000 | 0 | 7.52% | 0.00% |
| May 17, 2023 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | VP Global Marketing | A | Common Stock | 256450 | $0.00 | 256,450.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | InspireMD, Inc. | $NSPR | Gleason Shane Thomas | VP Global Marketing | A | Options to purchase common stock (right to buy) | 85480 | $0.00 | 85,480.0000 | 0 | 9999.99% | 0.00% |